HomeTOP STORIESCASI Pharmaceuticals GAAP EPS of -$2.56, revenue of $28.54M CASI Pharmaceuticals GAAP EPS of -$2.56, revenue of $28.54M By rogerjudd March 31, 2025 FacebookTwitterPinterestWhatsApp Post Content Previous articleEndra Life Sciences GAAP EPS of -$56.94Next articleOcuphire Pharma GAAP EPS of -$2.15, revenue of $10.99M latest articles The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds explore more The inflation process has shifted even as headline CPI declined – Federal Reserve Cerrado Gold reports Q4 results As H-1B Visa Program Changes, Skilled Foreign Workers Consider Leaving U.S. They Get Drunk Without Drinking: What It’s Like to Have Auto-brewery Syndrome Parents Who Borrowed for Children’s College Face Looming Deadline Watch: Artemis II’s journey so far… in 85 seconds
